drugset / Trial / NCT01075243

Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy

NCT01075243 ↗

Phase 4 Completed 401 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

GlaxoSmithKline will be conducting this trial to compare analgesic efficacy of paracetamol 1000 mg vs 650 mg. The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire study will be approximately 18 weeks. Each subject will have to come to the clinic for three visits (Screening, Treatment and Follow up visits).

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Paracetamol Caplet 1000mg vs Placebo Caplet; p <0.0001; Adjusted Mean DIfference 11.33 (95% CI 8.66 to 14.00); ANCOVA NCT01075243 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg —
Subject Acetaminophen Small molecule 1000 mg —

Indications

No indication recorded.